COST-EFFECTIVENESS ANALYSIS IN EARLY DETECTION OF PROSTATE-CANCER - AN EVALUATION OF 6 SCREENING STRATEGIES IN A RANDOMLY SELECTED POPULATION OF 2,400 MEN

被引：26

作者：

GUSTAFSSON, O

CARLSSON, P

NORMING, U

NYMAN, CR

SVENSSON, H

机构：

[1] LINKOPING UNIV,CTR MED TECHNOL ASSESSMENT,LINKOPING,SWEDEN

[2] SWEDISH INST HLTH SERV DEV,STOCKHOLM,SWEDEN

来源：

PROSTATE | 1995年 / 26卷 / 06期

关键词：

PROSTATE CANCER; SCREENING; ECONOMY; COST-EFFECTIVENESS ANALYSIS;

D O I：

10.1002/pros.2990260605

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Based on the findings in an early detection study for prostate cancer [Gustafsson et al.: J Urol 148:1827-1831, 1992] using digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate-specific antigen (PSA), a cost-effectiveness analysis was performed based on 6 screening strategies, namely: 1) DRE of all individuals; 2) TRUS of all individuals; 3) DRE, TRUS, and PSA analysis followed by reexamination of individuals with PSAs greater than or equal to 7 ng/ml; 4) DRE of individuals with PSAs of greater than or equal to 4 ng/ml; 5) TRUS of individuals with PSAs of greater than or equal to 4 ng/ml; 6) DRE and PSA analysis followed by TRUS on individuals with PSAs greater than or equal to 4 ng/ml. The detection rates of prostate cancer using these 6 strategies were 2.4%, 3.3%, 3.6%, 2.0%, 2.6%, and 3.2%, respectively. Except for costs per detected cancer, costs were also calculated per detected small cancer (less than or equal to 1.5 cm) and per detected cancer treated for cure. The cost calculations were based on total costs, i.e., direct plus indirect costs. When the 6 strategies were compared, taking into account the detection rate of cancers treated for cure and cost-effectiveness with respect to cancers treated for cure, strategies 1), 2), 3), and 4) were ruled out as less favorable than the remaining 2 strategies. TRUS of individuals with PSAs greater than or equal to 4 ng/ml (strategy 5) was the most cost-effective strategy and detected 80% of the cancers actually treated for cure. Screening with DRE and PSA analysis followed by TRUS of individuals with PSAs greater than or equal to 4 ng/ml (strategy 6) had a somewhat lower cost-effectiveness, but detected 90% of the cancers treated for cure. (C) 1995 Wiley-Liss, Inc.

引用

页码：299 / 309

页数：11

共 30 条

[11] Wilson JMG, Jungner G, Principles and Practice of Screening for Disease, (1986)
[12] Chodak GW, Keller P, Schoenberg HW, Assessment of screening for prostate cancer using the digital rectal examination, J Urol, 141, pp. 1136-1138, (1989)
[13] Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD, Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen, J Urol, 143, pp. 1146-1154, (1990)
[14] Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL, Measurment of prostate‐specific antigen in serum as a screening test for prostate cancer, N Engl J Med, 317, pp. 1156-1161, (1991)
[15] Mettlin C, Lee F, Drago J, Murphy GP, The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2,425 men, Cancer, 67, pp. 2949-2958, (1991)
[16] Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange P, Screening for prostate carcinoma with prostate specific antigen, J Urol, 147, pp. 841-845, (1992)
[17] Pedersen KV, Carlsson P, Varenhorst E, Lofman O, Berglund K, Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population, Br Med J [Clin Res], 300, pp. 1041-1044, (1990)
[18] Gustafsson O, Norming U, Almgard LE, Fredriksson A, Gustavsson G, Harvig B, Nyman CR, Diagnostic methods in the detection of Prostate cancer: a study on a randomly selected population of 2,400 men, J Urol, 148, pp. 1827-1831, (1992)
[19] Carlsson P, Pedersen K, Varenhorst E, Costs and benefits of early detection of prostate cancer, Elsevier Health Policy, 16, pp. 241-253, (1990)
[20] Varenhorst E, Carlsson P, Capik E, Lofman O, Pedersen K, Repeated screening for carcinoma of the prostate by digital rectal examination in a randomly selected population, Acta Oncol, 31, pp. 815-821, (1992)

← 1 2 3 →